Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein. A rapidly reemerging...

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of...

As the global spread of the Zika virus continues, efforts are underway to halt the disease’s transmission. While no licensed therapies or vaccines to protect against the Zika virus are currently...